Form 8-K - Current report:
SEC Accession No. 0001213900-24-078285
Filing Date
2024-09-13
Accepted
2024-09-13 08:06:59
Documents
15
Period of Report
2024-09-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214461-8k_china.htm   iXBRL 8-K 30691
2 LETTER FROM ASSENTSURE PAC DATED SEPTEMBER 13, 2024 ea021446101ex16-1_china.htm EX-16.1 2527
3 GRAPHIC ex16-1_001.jpg GRAPHIC 4237
  Complete submission text file 0001213900-24-078285.txt   208394

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE chhe-20240912.xsd EX-101.SCH 3054
5 XBRL LABEL FILE chhe-20240912_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE chhe-20240912_pre.xml EX-101.PRE 22385
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0214461-8k_china_htm.xml XML 3276
Mailing Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028
Business Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028 011-86-451-51719407
China Health Industries Holdings, Inc. (Filer) CIK: 0001309057 (see all company filings)

EIN.: 860827216 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51060 | Film No.: 241296487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)